98%
921
2 minutes
20
Background: Studies have demonstrated the shared and distinct etiologies of different depressive symptom domains. However, less is known about the effects of the three depressive symptom domains, namely the dysphoria, retardation, and vegetative domains, on inhibitory control function and proinflammatory cytokine profiles.
Methods: Our study enrolled 327 adolescent and adult patients with major affective disorders, namely bipolar disorder (n = 94) and major depressive disorder (n = 233). The three-depressive-symptom-domain model of the Montgomery-Åsberg Depression Rating Scale was used in the present study. All participants underwent the go/no-go task and were assessed for the levels of C-reactive protein (CRP) and tumor necrosis factor-α (TNF-α).
Results: Generalized linear models adjusted for age, sex, body mass index, and education years indicated that the dysphoria domain was positively associated with the levels of CRP (B = 0.034, p = 0.022) and TNF-α (B = 0.007, p = 0.020) and with errors in the go/no-go task (B = 0.155, p < 0.001). Additionally, in the go/no-go task, the retardation domain was positively correlated with response time (B = 5.418, p = 0.019), whereas the vegetative domain was negatively correlated with correct responses (B = -0.131, p = 0.015).
Discussion: Our findings suggest that different symptom domains of depression exert different effects on proinflammatory cytokine profiles and inhibitory control function, which may reflect the heterogeneity of depressive episodes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jpsychires.2025.08.023 | DOI Listing |
J Med Internet Res
September 2025
Institute of Social Medicine, Occupational Health and Public Health (ISAP), Medical Faculty, University of Leipzig, Leipzig, Germany.
Background: The loss of a loved one is a common yet stressful event in later life. Internet- and mobile-based interventions have been proposed as an effective treatment approach for individuals with prolonged grief.
Objective: The AgE-health study aimed to investigate the efficacy of an eHealth intervention, trauer@ktiv, in reducing prolonged grief symptoms in a sample of older adults.
JAMA Netw Open
September 2025
Department of Psychiatry, Psychosomatics, and Psychotherapy, University of Lübeck, Lübeck, Germany.
Importance: Patients with inflammatory rheumatic diseases (IRDs) frequently experience psychological distress; however, access to psychological support remains limited.
Objective: To investigate the effectiveness of a digital psychological intervention for individuals with IRDs.
Design, Setting, And Participants: Participants aged 18 years or older were recruited across Germany between February 22 and June 4, 2024, if they had been diagnosed with rheumatoid arthritis, psoriatic arthritis, or systemic lupus erythematosus and reported psychological distress and reduced quality of life.
Community Ment Health J
September 2025
Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, 10027, USA.
Guided by the Ottawa Decision Support Framework, we created a depression care decision aid for Latinx and African American individuals with major depressive disorder (MDD) at a network of Federally Qualified Health Centers. We surveyed 94 African American and Latinx individuals with MDD about their decision making needs. Focus groups elaborated on these preferences.
View Article and Find Full Text PDFActa Neurol Belg
September 2025
Neuroscience Research Australia, University of New South Wales, Sydney, Australia.
Objectives: Patients diagnosed with amyotrophic lateral sclerosis (ALS) typically describe symptoms of fatigue. Despite this frequency, the underlying mechanisms of fatigue are poorly understood, and are likely multifactorial. To help clarify mechanisms, the present systematic review was undertaken to determine the risk factors related to fatigue in ALS.
View Article and Find Full Text PDFMetab Brain Dis
September 2025
Department of Pharmacology, SVKM's Dr Bhanuben Nanavati College of Pharmacy, V.M. Road, Vile Parle (W), Mumbai, India.
This study aimed to evaluate the antidepressant potential of Nitazoxanide (NTZ), an antiprotozoal drug with known anti-inflammatory and neuroprotective properties, in a chronic unpredictable mild stress (CUMS)-induced mice model of depression. NTZ was administered at doses of 75, 150, and 300 mg/kg, and its effects were assessed through a series of behavioral tests, including the forced swim test, tail suspension test, actophotometer test, and social interaction test. NTZ treatment at 150 and 300 mg/kg significantly improved behavioral and biochemical outcomes, relieving depressive-like symptoms and restoring neurochemical balance.
View Article and Find Full Text PDF